NASHVILLE, Tenn.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced that it has received U.S. Food and Drug Administration (FDA) ...
In addition to reducing a hospital’s costs, addressing bleeding effectively and quickly is critical to avoiding major and minor complications for patients. As a leader in hemostasis, Baxter is ...
Floseal-only cases were also associated with nearly a half day shorter hospital stay, and 39 minute shorter surgical procedures.1 A separate cost-consequence model concluded that the decreased ...
Please provide your email address to receive an email when new articles are posted on . Use of Floseal Hemostatic Matrix in total knee arthroplasty safely provided improved control of blood loss and ...
A gel sometimes used during surgery to stop bleeding could cause misleading mammograms. Researchers reported seven cases in which a sealant called FloSeal, used during lumpectomies, mimicked malignant ...
Baxter International Inc. recently received clearance under the Medical Device Regulation for its Floseal Hemostatic Matrix device, a proven adjunct hemostatic agent effective in a wide range of ...
MAYWOOD, Ill. -- Dr. Kathleen Ward noticed something odd when she examined the mammogram of a patient who had recently undergone breast cancer surgery. The Loyola University Health System radiologist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results